Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.

GUESTS

Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics

Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs

Professor Colin Garner, Co Founder and Director, Antibiotic Research UK